Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Citizens has reaffirmed a Market Outperform rating and a $30.00 price target on Cipher Mining (NASDAQ:CIFR), citing quarterly results that the firm says validate the company’s transition from bitcoin mining to long-duration, contracted high-performance computing (HPC) cash flows. The analyst note highlights revenue growth, a large HPC lease backlog…
Citizens raised its price target on Cytokinetics to $96 from $88 and maintained a Market Outperform rating, citing launch activity for Myqorzo and upcoming Phase 3 data as catalysts. The stock trades near $70.10, offering roughly 37% upside to the new target, while other firms have also adjusted coverage following FDA approval and initial commercia…
Citizens reduced its price target on CoStar Group to $73 from $78 but left its Market Outperform rating intact. The cut reflects concern over the company’s back-half-weighted EBITDA guidance. While CoStar delivered a quarterly earnings beat, its guidance for the coming quarter and full year missed analyst expectations. Citizens highlighted continue…
A State Department cable dated Feb 18 instructs U.S. diplomats to oppose proposed laws that would restrict cross-border data flows, arguing such measures could raise costs, increase cybersecurity risks and limit artificial intelligence and cloud services. The guidance, signed by Secretary of State Marco Rubio, frames data localization and similar r…
Google said it disrupted a Chinese-linked hacking group tracked as UNC2814 or "Gallium" that had access to at least 53 organizations in 42 countries and may have been active in additional nations. The company, working with unnamed partners, terminated cloud projects, disabled internet infrastructure and shut down accounts the group used to operate,…
Casey Means, President Donald Trump’s nominee for U.S. surgeon general and an ally of Health Secretary Robert F. Kennedy Jr., will appear before the Senate Health, Education, Labor, and Pensions Committee on Wednesday in a confirmation hearing that was postponed from October. Means, 38, has close ties to Kennedy and to her brother, Calley Means, a …
Options traders are pricing in a notably modest move in Nvidia shares following the company's quarterly report, with options implying about a 5.6% move up or down. That anticipated swing is the smallest for a post-earnings period in at least three years, according to ORATS, and falls below recent averages for Nvidia and its historical reactions to …
Telsey increased its 12-month price objective for Home Depot to $435 from $410 and kept an Outperform rating after the retailer posted fourth-quarter fiscal 2025 results that exceeded expectations on several fronts. The company delivered adjusted EPS and comparable-sales beats, produced higher-than-expected operating margin, and reaffirmed its 2026…
Telsey Advisory Group increased its price target for Cava Group Inc to $88 from $85 and maintained an Outperform rating, pointing to strong near-term trends and a multi-year expansion strategy. The firm highlighted the company’s ambitious plan to grow to more than 1,000 restaurants by 2032, solid unit economics with average unit volumes near $3 mil…
Citizens has reaffirmed a Market Outperform rating and a $38.00 price target on Bowhead Specialty Holdings (BOW), arguing the company is well placed to benefit from persistently strong conditions in specialty casualty lines. The stock trades below the target, and recent quarterly results and revenue growth bolster the case for continued expansion i…
Citizens has reaffirmed a Market Outperform rating and a $22.00 price target on Benitec BioPharma (NASDAQ:BNTC). The stock trades at $11.12 with a $381 million market capitalization, implying nearly 100% upside to the analyst target. Interim clinical data for gene therapy candidate BB-301 - including a 24-month follow-up in the first patient and po…
Universal Display (OLED) trades below key moving averages, with stretched valuation (P/E ~21, P/FCF ~33) and a free cash flow yield near 3%. Recent technicals and rising short activity signal near-term downside if demand remains soft. We outline a swing short with precise entry, stop and target and the data-driven rationale behind it.
ASML has revised its outlook on demand drivers, identifying artificial intelligence as the primary force behind product sales after seeing new and significant AI-related capacity expansion among customers. The Netherlands-based lithography equipment maker reported 2025 full-year sales of 32.7 billion euros, a 15.6% increase, a gross profit margin o…
Citizens has reaffirmed a Market Outperform rating and an $825.00 price target on Axon Enterprise (NASDAQ: AXON), saying investor skepticism around AI has weighed on the stock despite the company’s robust fundamentals and recent quarterly outperformance. The firm highlighted Axon’s combination of physical devices, software and customer trust as pos…
Citizens has reiterated its Market Outperform rating on AxoGen, Inc. and maintained a $42.00 price target after the company reported quarterly revenue of $59.9 million and adjusted EPS of $0.07, both ahead of consensus. The quarter included roughly $9.1 million of one-time expenses tied to the BLA approval of Avance, and Citizens expects continued …
Morgan Stanley reduced its free cash flow-based price target for IBM to $247 from $304 while retaining an Equalweight rating, citing AI disruption risk after the Claude Code tool announcement. The firm noted acute volatility across software and services peers, adjusting its outlook amid a roughly 20% share decline over the past month and 22% year-t…
Citizens reiterated a Market Outperform rating on American Tower (AMT) and sustained a $260 price target, highlighting the stock's valuation on a 2026 adjusted funds from operations (AFFO) basis and a robust dividend profile. The firm contrasted the infrastructure REIT's predictable cash flows with higher-risk AI-related names, while noting mixed v…
Citizens maintained a Market Outperform rating on Addus HomeCare (ADUS) and left its 2026-2027 EBITDA forecasts unchanged, assigning a $150.00 price target. The firm flagged both acquisition potential and organic growth drivers, while Addus reported better-than-expected fourth-quarter 2025 results but saw its stock fall in after-hours trading.
Citizens reaffirmed a Market Perform rating on Avanos Medical (AVNS), leaving its 2027 EPS estimate at $1.25 and valuing the stock at roughly 11 times that estimate. The analyst house pointed to meaningful progress in 2025 - led by SNS business improvements, operating efficiency, capital allocation, and portfolio optimization - but said some commer…
Deutsche Bank reduced its recommendation on Beiersdorf AG (OTC: BDRFY) from Buy to Hold on Wednesday while keeping a EUR105.00 price target. The bank cited the stock’s recent relative strength and valuation metrics - including elevated P/E multiples and forward pricing that appear to bake in consumer like-for-like growth - as the rationale for the …
China announced it has met obligations tied to the U.S. Section 301 trade statute and urged Washington not to pursue further punitive measures, after the U.S. Trade Representative indicated ongoing investigations that could result in more tariffs. Beijing said it prefers to resolve issues through existing economic and trade consultation channels bu…
Zimbabwe has ended negotiations on a proposed $367 million bilateral health Memorandum of Understanding with the United States, saying the terms would have required prolonged sharing of biological resources and epidemiological data without guarantees of access to resulting medical innovations. The U.S. embassy said it will wind down health support.…
U.S. stock index futures ticked higher on Wednesday after a period of volatility as investors digested mixed signals about the economic impact of rapid AI investment and navigated ongoing uncertainty over newly announced tariffs. Nvidia’s quarterly results, due after the close, were the focal point for investors seeking confirmation that surging ca…
JP Morgan raised its long-term gold price forecast by 15% to $4,500 an ounce while maintaining a year-end 2026 projection of $6,300. The bank attributed the revision to stronger-than-expected central bank buying, official statements about U.S. Treasury divestment and a trend of some countries moving revenues from the dollar into the Chinese renminb…
UBS initiated coverage of CEVA Inc. (NASDAQ:CEVA) with a buy rating and a $27.00 price target, implying roughly 34% upside from the stock's current $20.13 level. The research note points to CEVA's dominant wireless and connectivity IP position, high gross margins, and a nascent but accelerating edge AI royalty stream as drivers of valuation expansi…
